We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Kate C Robins has been assisting clients through the H1B Visa process since 2020.

As of 2022, Kate C Robins has succesfully submitted and recieved certification for 255 cases.

Kate C Robins is located in Boston, MA, and has represented 10 employers for the H1B Visa Process

260
Cases Handled
255
Cases Certified
98.08%
Approval

Cases Handled by Kate C Robins

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-23086-879089 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23072-843319 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23060-814822 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-22049-915176 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Theapeutics 2022
I-200-22055-929751 Certified Molecular And Cellular Biologists Scientific Research And Development Services Intellia Therapeutics 2022
I-200-23243-311018 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23242-308399 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics Inc 2023
I-200-23222-253910 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23172-132472 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23152-069258 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023